ArticleThe New England journal of medicine2019
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
Arnon P Kater et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it
ArticleThe New England journal of medicine2019
Arnon P Kater et al.PubMed ↗Publisher ↗
No numbers read from the abstract.